Single IRB review for multisite studies is “all about getting medications and treatments to patients faster without compromising patient protections.”
Feeling like you have no control at work? Try practicing “self leadership.”
“When we think about diversity, we have to think beyond race and ethnicity… We have to find ways we can make a difference.”
As the issues surrounding participant diversity become better understood globally, more eyes are turning to the next frontier in drug development diversity, equity, and inclusion: the clinical research workforce.
This article outlines the creation and functioning of an advisory board at Janssen intended, in part, to obtain feedback on strategies and solutions intended for patients, with a primary focus on clinical trial design.